|
|
Volumn 49, Issue 10, 2008, Pages 1186-1196
|
|
Basics and management of glucocorticoid-induced osteoporosis;Grundlagen und management der glukokortikoidinduzierten osteoporose
|
|
Author keywords
Adrenal gland; Bone mass density; Corticosteroids; Fracture risk; Osteoporosis
|
|
Indexed keywords
25 HYDROXYVITAMIN D;
ALENDRONIC ACID;
ALFACALCIDOL;
ALKALINE PHOSPHATASE;
C REACTIVE PROTEIN;
CALCITONIN;
CALCIUM;
COLECALCIFEROL;
CREATININE;
DEXAMETHASONE;
ETIDRONIC ACID;
FLUORIDE SODIUM;
GLUCOCORTICOID;
IBANDRONIC ACID;
PAMIDRONIC ACID;
PARATHYROID HORMONE[1-34];
PHOSPHATE;
PREDNISOLONE;
PREDNISONE;
RALOXIFENE;
RISEDRONIC ACID;
STRONTIUM RANELATE;
THYROTROPIN;
ZOLEDRONIC ACID;
ALKALINE PHOSPHATASE BLOOD LEVEL;
ANAMNESIS;
BONE DENSITY;
BONE MASS;
BONE METABOLISM;
CORTICOSTEROID INDUCED OSTEOPOROSIS;
CORTICOSTEROID THERAPY;
CREATININE BLOOD LEVEL;
DIAGNOSTIC IMAGING;
DUAL ENERGY X RAY ABSORPTIOMETRY;
FRAGILITY FRACTURE;
HUMAN;
LABORATORY TEST;
OSTEOLYSIS;
PATHOPHYSIOLOGY;
PATIENT EDUCATION;
PHOSPHATE BLOOD LEVEL;
PHYSICAL EXAMINATION;
REVIEW;
RISK FACTOR;
THYROTROPIN BLOOD LEVEL;
TREATMENT DURATION;
BONE DENSITY;
BONE DENSITY CONSERVATION AGENTS;
CALCIUM;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FRACTURES, SPONTANEOUS;
GLUCOCORTICOIDS;
HUMANS;
LONG-TERM CARE;
OSTEOPOROSIS;
RISK FACTORS;
SPINAL FRACTURES;
|
|
EID: 53149089016
PISSN: 00209554
EISSN: None
Source Type: Journal
DOI: 10.1007/s00108-008-2118-8 Document Type: Review |
|
Times cited : (6)
|
|
References (29)
|
